batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. ASH 2023 – Genmab's son of Darzalex in focus 14 December 2023 ASH 2023 – Sympatico gives Imbruvica a second chance 14 December 2023 ASH 2023 – a short-lived success for Poseida 11 December 2023 ASH 2023 – lupus target could work in lymphoma too 10 December 2023 ASH 2023 – lacutamab’s late-line promise on hold 10 December 2023 ASH 2023 – Incyte hopes to add axatilimab to the arsenal 10 December 2023 ASH 2023 – Novartis sees early TIM-3 promise 9 December 2023 ASH 2023 – Bristol follows in Talvey’s slipstream 9 December 2023 Load More